Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
2-Phenylimidazo[2,1-i]purin-5-ones: structure-activity relationships and characterization of potent and selective inverse agonists at Human A3 adenosine receptors.
Bioorg Med Chem. 2003 Feb 6;11(3):347-56. doi: 10.1016/s0968-0896(02)00456-x.
Bioorg Med Chem. 2003.
PMID: 12517430
Free PMC article.
[(3)H]8-Ethyl-4-methyl-2-phenyl-(8R)-4,5,7,8-tetrahydro-1H-imidazo[2,1-i]-purin-5-one ([(3)H]PSB-11), a novel high-affinity antagonist radioligand for human A(3) adenosine receptors.
Müller CE, Diekmann M, Thorand M, Ozola V.
Müller CE, et al. Among authors: ozola v.
Bioorg Med Chem Lett. 2002 Feb 11;12(3):501-3. doi: 10.1016/s0960-894x(01)00785-5.
Bioorg Med Chem Lett. 2002.
PMID: 11814828
Item in Clipboard
Peptidomimetic plasmepsin inhibitors with potent anti-malarial activity and selectivity against cathepsin D.
Zogota R, Kinena L, Withers-Martinez C, Blackman MJ, Bobrovs R, Pantelejevs T, Kanepe-Lapsa I, Ozola V, Jaudzems K, Suna E, Jirgensons A.
Zogota R, et al. Among authors: ozola v.
Eur J Med Chem. 2019 Feb 1;163:344-352. doi: 10.1016/j.ejmech.2018.11.068. Epub 2018 Nov 29.
Eur J Med Chem. 2019.
PMID: 30529637
Free PMC article.
Item in Clipboard
Azole-based non-peptidomimetic plasmepsin inhibitors.
Kinena L, Leitis G, Kanepe-Lapsa I, Bobrovs R, Jaudzems K, Ozola V, Suna E, Jirgensons A.
Kinena L, et al. Among authors: ozola v.
Arch Pharm (Weinheim). 2018 Sep;351(9):e1800151. doi: 10.1002/ardp.201800151. Epub 2018 Jul 31.
Arch Pharm (Weinheim). 2018.
PMID: 30063266
Item in Clipboard
Cite
Cite